A Phase II Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Immunogenicity and Safety of TetraVax-DV in Healthy Adults in Taiwan
Latest Information Update: 16 Aug 2019
At a glance
- Drugs TV 003 (Primary)
- Indications Dengue
- Focus Pharmacodynamics
- Sponsors Medigen Vaccine Biologics
- 12 Aug 2019 Status changed from active, no longer recruiting to completed.
- 07 Aug 2019 New trial record